Drugging MYCN through an Allosteric Transition in Aurora Kinase A-Reference-Cited by-同舟云学术

Drugging MYCN through an Allosteric Transition in Aurora Kinase A

Published:2014-09 Issue:3 Volume:26 Page:414-427
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Gustafson William Clay,Meyerowitz Justin Gabriel,Nekritz Erin A.,Chen Justin,Benes Cyril,Charron Elise,Simonds Erin F.,Seeger Robert,Matthay Katherine K.,Hertz Nicholas T.,Eilers Martin,Shokat Kevan M.,Weiss William A.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference46 articles.

1. PHENIX: a comprehensive Python-based system for macromolecular structure solution;Adams;Acta Crystallogr. D Biol. Crystallogr.,2010

2. Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma;Brockmann;Cancer Cell,2013

3. Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins;Carmena;Curr. Opin. Cell Biol.,2009

4. Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer;Carol;Cancer Chemother. Pharmacol.,2011

5. Paracrine signaling through MYCN enhances tumor-vascular interactions in neuroblastoma;Chanthery;Sci. Transl. Med.,2012

Cited by 233 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aurora Kinase A Is Overexpressed in Human Retinoblastoma and Correlates with Histopathologic High-Risk Factors;The American Journal of Pathology;2024-09

2. Selective Aurora A-TPX2 Interaction Inhibitors Have In Vivo Efficacy as Targeted Antimitotic Agents;Journal of Medicinal Chemistry;2024-08-27

3. Aurora Kinase A inhibition enhances DNA damage and tumor cell death with 131I-MIBG therapy in high-risk neuroblastoma;EJNMMI Research;2024-06-13

4. Targeting AURKA to induce synthetic lethality in CREBBP-deficient B-cell malignancies via attenuation of MYC expression;Oncogene;2024-05-23

5. KAP1 stabilizes MYCN mRNA and promotes neuroblastoma tumorigenicity by protecting the RNA m6A reader YTHDC1 protein degradation;Journal of Experimental & Clinical Cancer Research;2024-05-14